Clinical Trial Update: This is Comparative Study in Normal Healthy Subjects to Evaluate Pharmacokinetics, Safety, Tolerability of Bmab 1200 -Autoinjector (AI) After Single Subcutaneous Injection (45 mg) in Comparison With Bmab 1200 -Prefilled Syringe (PFS). [Phase 1]

View source ↗

Summary

Phase 1 study in healthy subjects comparing pharmacokinetics, safety, and tolerability of Bmab 1200 delivered via autoinjector versus prefilled syringe; the stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• To Severe Chronic Plaque Psoriasis

Drugs mentioned

• Bmab 1200

Snippet

Sponsor: Biocon Biologics UK Ltd | Conditions: Moderate to Severe Chronic Plaque Psoriasis | Phase 1 | Status: COMPLETED